Although the use of newer insulin analogues, continuous glucose monitors (CGMs) and hybrid closed-loop systems has lowered the risk [3, 4], the majority of individuals with type 1 diabetes still frequently experience non-severe (<3.9 mmol/l [70 mg/dl]) hypoglycaemia [5]. The gene discussed is INS; the disease is Hypoglycemia.